Showing results (211-220 of 679) with videos related to
Sort By:
Pageof 68
Revue Medicale De Liege|June 7, 2011
[Medication of the month. Femoston Low (0.5 mg estradiol plus 2.5 mg dydrogesterone) for menopausal hormonal replacement therapy]A J Scheen, U GaspardRevue Medicale De Liege|January 12, 2023
[EMPA-KIDNEY: empagliflozin in chronic kidney disease]P Delanaye, A J ScheenRevue Medicale De Liege|May 8, 2009
[Vildagliptin (Galvus) and fixed combination vildagliptine-metformin (Eucreas) in the treatment of type 2 diabetes]A J Scheen, N PaquotRevue Medicale De Liege|April 9, 2020
[Extended indications for antidiabetic agents with cardio-renal protection in updated international recommendations for themanagement of at risk patients with type2 diabetes]A J Scheen, N PaquotRevue Medicale De Liege|August 15, 2000
[Recommendations for the treatment of obesity]F Luyckx, A J ScheenRevue Medicale De Liege|November 21, 2002
[Clinical study of the month. The MRC/BHF Heart Protection Study]H Kulbertus, A J ScheenRevue Medicale De Liege|April 8, 2017
[About the choice between a DPP-4 inhibitor and a SGLT 2 inhibitor tor treating type 2 diabetes]A J Scheen, N PaquotRevue Medicale De Liege|April 8, 2017
[Optimizing basal insulin therapy in type 2 diabetes]A J Scheen, N PaquotRevue Medicale De Liege|July 19, 2003
[Statins for cardiovascular prevention: is there still a place for cholesterol measurement?]A J Scheen, H KulbertusPageof 68